Human adult stem cells as targets for cancer stem cells: Evolution; Oct-4 gene and cell-to-cell communication

Cancer and Stem Cells

Volumn , Issue , 2008, Pages 147-187

  Trosko, James E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988331453     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Dobzhansky, T. (1975) Nothing in Biology makes sense except in the light of evolution. Am. Biol. Teachers, 35, 125-129.
2. Hanahan, D. and Weinberg, R.A. (2000). Hallmarks of cancer. Cell, 100, 57-70.
3. Al Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Nat. Acad. Sci. USA, 100, 3983-3988.
4. Markert, C.L. (1968). Neoplasia: A disease of differentiation. Cancer Res., 28, 1908-1914.
5. Markert, C. L. (1984). Genetic control of cell interactions in chimeras. Develop Genet., 4, 267-279.
6. Pierce, B. (1974). Neoplasms, differentiation and mutations. Am. J. Pathol., 77, 103-118.
7. Potter, V.R. (1978). Phenotypic diversity in experimental hepatomas: Concept of partially blocked ontogeny. Br. J. Cancer, 38, 1-23.
8. Kerbel, R.S., Frost, P., Liteplo, R., Carlow, D.A., and Elliot, B.E. (1984). Possible epigenetic mechanisms of tumor progression: Induction of high frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. J. Cell Physiol, 3, 87-97.
9. Tlsty, T.D., Briot, A., Gualberto, A., Hall, I., Hess, S., Hixon, M., Kuppuswamy, D., Romanov, D., Sage, M., and White, A. (1995). Genomic instability and cancer. Mutation Res, 337, 1-7.
10. P.W. Laird. (2005). Cancer epigenetics. Hum. Mol. Genet., 14, R65-R76.
11. Boveri, T. (1914). Zurfrage der Entstehung Maligner Tumoren. Jena: Gustav Fisher.
12. Cleaver, J.E. and Trosko, J.E. (1970). Absence of excision of ultraviolet-induced cyclobutane dimers in Xeroderma pigmentosum. Photochem. Photobiol., 11, 547-550.
13. Maher, V.M. and McCormick, J.J. (1976). Effect of DNA repair on the cytotoxicity and mutagenicity of UV irradiation and of chemical carcinogens in normal and xeroderma pigmentosum cells. In: J.M. Yuhas, R.W. Tennant and J.D. Regan (Eds.), Biology of Radiation Carcinogenesis (pp. 129-145). New York: Raven Press.
14. Warren, S., R.A. Schultz, C.C. Chang, M.H. Wade and Trosko, J.E. (1981). Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc. Natl. Acad. Science USA, 78, 3133-3137.
15. Brash, D. E., Rudolph, J.A., Simon, X., Lin, A. and McKenna, G.J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas. Proc. Natl. Acad. Sci. USA, 88, 10124-10128.
16. Ames, B.N., Durston, W. E., Yamasaki, E. and Lee, F. D. (1973). Carcinogens are mutagens a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA, 70, 2281-2285.
17. Marsh, D.J. and Zori, R.T. (2002). Genetic insights into famial cancers-update and recent discoveries. Cancer Letters, 181, 125-164.
18. Evans, W.H. and Martin, P.E.M. (2002). Gap junctions: Structure and Function. Molec. Membr. Biol., 19, 121-136.
19. Cruciani, V. and Mikalsen, S.-O. (2005). The connexin gene family in mammals. Biol Chem., 386, 325-332.
20. Willecke, K., Eiberger, J., Degen, J., Eckhardt, D., Romauldi, A., Guldenagel, M., Duetsch, U. and Sohl, G. (2002). Structural and functional diversity of connexion genes in the mouse and human genome. Biol. Chem., 383, 725-737.
21. Eagle, H. (1965). Growth inhibitor effects of cellular interactions. Isreal J. Med. Sci., 1, 1220-1228.
22. Revel, J.P. (1988). The oldest multicellular animal and its junctions. In: Hertzberg, E.L. and Johnson, R. (Eds.), Gap Junction (pp 135-149). N.Y.: Alan Liss, Inc.
23. Loewenstein, W.R. (1966). Permeability of membrane junctions. Ann. N.Y. Acad. Sci., 137, 441-472.
24. Trosko, J.E. (2007). Stem cells and cell-cell communication in the understanding of the role of diet and nutrients in human diseases. J. Fd. Hyg. Safety, 22, 1-14.
25. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblasts cultures by defined factors. Cell, 126, 663-676.
26. Shi, Y. (2004). Caspase activation, inhibition, and reactivation: A mechanistic view. Protein Science, 13, 1979-1987
27. Wilson, M.R., Close, T.W. and Trosko, J.E. (2000). Cell population dynamics (apoptosis, mitosis and cell-cell communication) during disruption of homeostasis. Exp. Cell Res., 254, 257-268.
28. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M. and Fuchs, E. (2004). Defining the epithelial stem cell niche in skin. Science, 303, 359-363.
29. Juckett D. A. (1987). Cellular aging (the Hayflick limit) and species longevity: a unification model based on clonal succession. Mech Ageing Devel., 38, 49-71.
30. Kalimi and Lo blastocyte lack og GJ Lo, C.W. (1996). The role of gap junction membrane channels in development. J. Bioenerget. Biomembr., 28, 379-385.
31. Trosko, J.E., Chang, C.C., Wilson, M.R., Upham, B.L., Hayashi, T. and wade, M. (2000). Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods, 20, 245-264.
32. de Rooij, D. G., Lok, D., Wennk, D. (1985). Feedback regulation of the proliferation of the undifferentiated spermatogonia in the Chinese hamster by differentiating spermatogonia. Cell Tissue Kinet, 18, 71-81.
33. Kimchi, A., Wang, X. F., Weinberg, R. A., Cheifetz, S. and Massague, J. (1988). Absence of TGF-b receptors and growth: Inhibitory responses in retinoblastoma cells. Science, 290, 196-198.
34. Borek, C. and Sachs, L. (1966). The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc. Natl. Acad. Sci. USA, 56, 1705-1711.
35. Yamasaki, H. and Naus, C.C.G. (1996). Role of connexion genes in growth control. Carcinogenesis, 17, 1199-1213.
36. Csete, M. (2005). Oxygen in the cultivation of stem cells. Ann. N.Y. Acad. Sci., 1049, 1-8.
37. Fialkow, P. J. (1979). Clonal origin of human tumors. Am. Rev. Med., 30, 135-176.
38. Nowell, P.C. (1976). The clonal evolution of tumour cell populations. Science, 194, 23-28.
39. Sell, S. (1993). Cellular origin of cancer: De-differentiation or stem cell maturation arrest? Environ. Health Perspect., 101, 15-26.
40. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Berstein, B.E., and Jaenisch, R. (2007). In vitro reprogramming of fibroblasats into a pluripotent ES-cell-like state. Nature, 448, 318-323.
41. Macerali N., Sriharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadfeld, M., Yachechko, R., Tchieu, J. Jaenisch, R., Plath, K. and Hochedlinger, K. (2007). Directly reprogrammed fibroblast show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell, 1, 55-70.
42. Okita, K., Ichisak, T. and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature, 488, 313-319.
43. Land, H., Parada, I.E. and Weinberg, R.A. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596-602.
44. Hayflick, L. (1965). The limited in vitro lifespan of human diploid cell strains. Exp. Cell Res., 37, 614-636.
45. Berenblum, P.M. (1954). A speculative review: The probable nature of promoting action and its significance in the understanding of the mechanisms of carcinogenesis. Cancer Res., 14, 471-477.
46. Yamagiwa, K. and Ichikawa, K. (1977). Experimental study of the pathogenesis of carcinoma. CA Cancer J. Clin., 27, 174-181.
47. Knudson, A.G. (1971). Mutations and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820-823.
48. Yang, Z., Sui, Y., Xiong, S., Liour, S.S., Phillips, A.C. and Ko, L. (2007). Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation. Nucleic Acid Res., 35(6), 1919-1932.
49. Trosko, J.E. (2001). Is the concept of tumor promotion a useful paradigm? Molec. Carcinogen., 39, 131-137.
50. Goodman, J.A. (2001). Operational reversibility is a key aspect of carcinogenesis. Toxicol. Sci., 64, 147-148.
51. Trosko, J.E. and Tai, M.-H. (2006). Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: Role of inflammation on the promotion of initiated cells. In Dittmar, T., Zaeker, K.S. and Schmidt, XXX (Eds.), Infections and Inflammation: Impacts on Oncogenesis (Contributions to Microbiology, Vol. 13, pp. 45-65). K. Karger AG.
52. Klaunig, J. and Ruch, R.J. (1987). Strain and species effects on the inhibition of hepatocyte intercellular communication by liver tumor promoters. Cancer Letters, 36, 161-168.
53. Yotti, L.P., Chang, C.C. and Trosko, J.E. (1979). Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science, 206, 1089-1091.
54. Trosko, J.E. and Chang, C.C. (1988). Nongenotoxic Mechanisms in carcinogenesis: role of inhibited intercellular communication. In: Hart, R.W. and Hoerger, F.D. (Eds), Banbury Report 31: Carcinogen Risk Assessment: New Directions in the Qualitative and Quantitative Aspects (pp. 139-170). Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory.
55. Sai, K., Kanno, J., Hasegawa, R., Trosko, J.E., and Inoue, T. (2000). Prevention of the down regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol. Carcinogenesis, 21, 1671-1676.
56. Nielson, M., Ruch, R.J., and Vang, O. (2000). Reservatrol reverses tumor-promoter- induced inhibition of gap junctional intercellular communication. Biochem. Biophys. Res. Commun., 275, 804-809.
57. Upham, B.L. GuTzvic, M., Scott, J., Carbone, J.M., Blaha, L., Coe, C. Li, L. L., Rummel, A.M., and Trosko, J.E. (2007). Inhibition of Gap Junctional Intercellular Communication and Activation of Mitogen-Activated Protein Kinase by Tumor- Promoting Organic Peroxides and Protection by Resveratrol. Nutrition and Cancer, 57(1), 38-47.
58. Na, H.-K., Wilson, M.R., Kang, K.S., Chang, C.C., Grunberger, D. and Trosko, J.E. (2000). Restoration of gap junctional intercellular communication by caffeic acid phenethyl ester (CAPE) in a ras-transformed rat liver epithelial cell line. Cancer Letters, 157, 31-38.
59. Ruch, R.J., Madhukar, B.V., Trosko, J.E., and Klaunig, J.E. (1993). Reversal of ras- induced inhibition of gap junctional intercellular communication, transformation and tumorigenesis by lovastatin. Molec. Carcinogen., 7, 50-59.
60. Nakamura, Y., Chang, C.C., Mori, T., Sato, K., Ohtsuki, K., Upham, B.L., and Trosko, J.E. (2005). Augmentation of differentiation and gap junction fubction by kaempferol in partially-differentiation colon cancer cells. Carcinogenesis, 26, 665-671.
61. Ogawa, T., Hayashi, T., Tokunou, M., Nakachi, K., Trosko, J.E., Chang, C.C., and Yorioka, N., (2005). Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin43 gene locus. Cancer Res., 65, 9771-9778.
62. Nakamura, Y., Yoshikawa, N., Hiroki, I., Sato, K., Ohtsuki, K., Chang, C.C., Upham, B.L., and Trosko, J.E. (2005). ß- Sitosterol, From Psyllium Seed Husk (Plantago ovata Forsk), Restores Gap Junctional Intercellular Communication in Ha-ras Transfected Rat Liver Cells. Nutrition Cancer, 5, 218-225.
63. Trosko, J.E. and Ruch, R.J. (1998). Cell-cell communication in carcinogenesis. Front. Biosci., 3, 208-236.
64. Loewenstein, W.R and Kanno, Y. (1966). Intercellular communication and the control of tissue growth: Lack of communication between cancer cells. Nature, 209, 1248-1249.
65. Cleaver, J.E. (1978). Xeroderma pigmentosum: genetic and environmental influences in skin carcinogenesis. International Journa of Dermatology, 17, 435-444.
66. Warren, S., Schultz, R.A., Chang, C.C., Wade, M.H. and Trosko, J.E. (1981). Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc. Natl. Acad. Science USA, 78, 3133-3137.
67. Ames, B.N., Lois, Swirsky, Gold, L.S., and Shigenaga, M.K. (1996). Cancer Prevention, Rodent High-Dose Cancer Tests, And Risk AssessmentRisk Analysis, 16, 613-617.
68. Trosko, J.E. and Upham, B.L. (2005). The emperor wears no clothes in the field of carcinogen risk assessment: Ignored concepts in cancer risk assessment. Mutagenesis, 20, 81-92.
69. Thilly, W.G. (2003). Have environmental mutagens caused oncomutations in people? Nat. Genet., 34, 255-259.
70. Upham, B.L., Weis, L.M. and Trosko, J.E. (1998). Modulated gap junctional intercellular communication as a biomarker of PAH epigenetic toxicity: structure-function relationship. Environ. Health Perspect. 106(Suppl 4), 975-981.
71. Weis, L.M., Rummel, A.M., Masten, S.J., Trosko, J.E. and Upham, B.L. (1998). Bay or baylike regions of polycyclic aromatic hydrocarbons were potent inhibitors of gap junctional intercellular communication. Environ. Health Perspect., 106, 17-22.
72. Tai, M.H., Upham, B.L., Olson, L.K., Tsao, M.S., Reed, D.N., and Trosko, J.E. (2007). Cigarette smoke condensate inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int. J. Cancer, 120, 1855-1862.
73. Minsk, B. and Illensee, K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA, 72, 3585-3589.
74. Trosko, J. E. (2006). From adult stem cells to cancer stem cells: Oct-4 gene, cell-cell communication and hormones during tumor promotion. Ann. N.Y. Acad. Sci., 1089, 36-58.
75. Wang X. and Harris, C. (1997). p53 tumor- suppressor gene: clues to molecular carcinogenesis. J. Cell Physiol., 173, 247-255.
76. Barcellos-Hoff, M.H. (2001). Three down and counting: The transformation of human mammary cells from normal to malignant in three steps. Trends Molec. Med., 7, 142-143.
77. Bissell, M.J. and Radisky, D. (2001). Putting tumors in context. Nature Rev. Cancer, 1, 46-54.
78. Trosko, J.E., Chang, C.C., Upham, B. and Wilson, M. (1998). Epigenetic toxicology as toxicant-induced changes in intracellular signalling leading to altered gap junctional intercellular communication. Toxicol. Lett., 102-103, 71-78.
79. Potter, V.R. (1973). Biochemistry of cancer. In Holland, J. and Frei, E (Eds.), Cancer Medicine (pp. 178-192). Philadelphia: Lea, E. and Febiger.
80. Al Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.I. and Clarke, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA, 100, 3983-3988.
81. Webster, J.D., Yusbasiyan-Gurkan, V., Trosko, J.E., Chang, C.C., and Kiupel, M. (2007). Expression of the embryonic transcription factor Oct4 in Canine neoplasms: A potential marker for stem cell subpopulations in neoplasia. Vet. Pathol., 44, in press.
82. Chang, C.C., Trosko, J.E., El-Fouly, M.H., Gibson, D.R. and D'Ambrosio, S.M. (1987). Contact insensitivity of a subpopulation of normal human fetal kidney epithelial cells and of human carcinoma cell lines. Cancer Res., 47, 1634-1645.
83. Kao, C.Y., Nomata, K., Okley, C.S., Welsch, C.W. and Chang, C.C. (1995). Two types of normal human breast epithelial cells derived from reduction mammoplasty: Phenotypic characterization and response to SV40 transfection. Carcinogenesis, 16, 531-538.
84. Linning, K.D., Tai, M.H., Madhukar, B.V., Chang, C.C., Reed, D.N., Ferber, S., Trosko, J.E., and Olson, L.K. (2004). Redox-mediated enrichment of self-renewing adult human pancreatic cells which possess endocrine differentiation potential. Pancreas, 29, e64-e76.
85. Lin, T.-M., Tsai, J.-L., Lin, S.-D., Lai, C.-S., and Chang, C-C. (2005). Accelerated Growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Stem Cells Devel., 14, 92-102.
86. Yang, Y.C., S.W. Wang, H. Y. Hung, C.C. Chang, I.C. Wu, Y.L. Huang, T. M. Lin, J. L. Tsai, A. Chen, F.C. Kuo, W.M. Wang and D.C. Wu. (2007). Isolation and characterization of human gastric cell lines with stem cell phenotypes. J. Gastroenterology Hepatology, doi:1111/j.1440-1746.2007.05031.x.
87. Matic, M., Evans, W.H., Brink, P.R. and Simon, M. (2002). Epidermal cells do not communicate through gap junctions. J. Invest. Dermat., 118, 110-116.
88. Matic, M., Petrov, I.N., Chen, S., Wang, C., Dimitrijevich, S.D., and Wolosin, J.M. (1997). Stem cells of the corneal epithelium lack connexins and metabolic transfer capacity. Different., 61, 251-260.
89. Kang, K.S., Sun, W., Nomata, K., Morita, I., Cruz, A., Liu, C.J., Trosko, J.E. and Chang, C.C. (1998). Involvement of tyrosine phosphorylation of p185 c-erB2/neu in tumorigenicity by X rays and neu-oncogene in human breast epithelial cells. Molec. Carcinogen., 21, 225-233.
90. Nakano, S., Ueo, H., Bruce, S.A. and Ts'o, P.O.P. (1985). A contact-insensitive subpopulation in Syrian hamster cell cultures with a greater susceptibility to chemically induced neoplastic transformation. Proc. Natl. Acad. Sci. USA, 82, 5005-5009.
91. Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M.A. and Daidone, M.A. (2005). Isolation and In vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res., 65, 5506-5511.
92. Chang, C.C., Sun, W., Cruz, A., Saitoh, M., Tai, M.H. and Trosko, J.E. (2001). A human breast epithelial cell type with stem cell characteristics as targets for carcinogenesis. Radiat. Res., 155, 201-207.
93. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
94. Okamoto, K., Okazawa, H., Okuda, A., Sakai, M., Muramatsu, M. and Hamada, H. (1990). A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell, 60, 461-472.
95. Niwa, H., Miyazaki, J. and Smith, A.G. (2000). Quantitative expression of 0ct3/4 defines differentiation, de-differentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376.
96. Rosner, M.H., Vigano, M.A., Ozato, K., Timmons, P.M., Poirier, F., Rigby, P.W. and Staudt, L.M. (1990). A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature, 345, 686-692.
97. Monk, M and Holding, C. (2001). Human embryonic genes re-expressed in cancer cells. Oncogene, 20(20), 8085-8091.
98. Tai, M.H., Chang, C.C., Kiupel, M., Webster, J.D. and Trosko, J.E. (2005). Oct-4 expression in adult stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis, 26, 495-502.
99. Momiyama, M., Omori, Y., Isizaki, Y., Nishikawa, Y., Tokairin, T., Ogawa, J. and Enomoto, E. (2003). Connexin 26 mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci., 94: 501-507.
100. Barcellos-Hoff, M.H. (2001). It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment. J. Mammary Gland Neoplasm, 6, 213-221.
101. Atlasi, Y., Mowla, S.T., Ziaee, S.A. and Bahrami, A.R. (2007). Oct-4, an embryonic stem cell maker is highly expressed in bladder cancer. Internatl. J. Cancer, 120, 1598-1602.
102. Kelly, P.N., Dakic, A., Adams, J.M., Nutt, S.L. and Strasser, A. (2007). Tumor growth need not be driven by rare cancer stem cells. Science, 317, 337.
103. Umemoto, T. Yamato, M., Nishida, K., Yang, J., Tano, Y. and Okano, T. (2005). Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells, 24, 86-94.
104. Kim; M., Turnquist, H., Jackson, J., Sgaglas, M., Yan, Y., Gong, M., Dean, M., Sharp, J.G., and Cowan, K. (2002). The multidrug resistance transporter ABCG2 (Breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clinical Cancer Res., 8, 22-28.
105. Trosko, J.E. (2007). Stem cells and cell-cell communication in the understanding of the role of diet and nutrients in human diseases. J. Fd. Hyg. Safety, 1-14.
106. Milton, K. (2000). Back to basics: Why foods of wild primates have relevance for modern human health. Nutrition, 16, 480-483.
107. Kiple, K.F. (Ed). (2000). The Cambridge World History of Food. Cambridge University Press.
108. Teaford, M.F. and Ungar, P.S. (2000). Diet and the evolution of the earliest human ancestors. Proc. Natl. Acad. Sci. USA, 97, 13506-13511.
109. Mariani-Constantini, A. (2000). Natural and cultural influences on the evolution of the human diet: Background of the multifactorial processes that shaped the eating habits of Western societies. Nutrition, 16, 483-486.
110. Popkin, B.M. (2007). The world is fat. Sci. Amer., 297, 88-95
111. Trosko, J.E. and Ruch, R. J. (2002). Gap junctions as therapeutic targets. Curr. Drug Targets, 3, 465-482.
112. Franco, E.L., Correa, P., Santella, R.M., Wu, X., Goodman, S.N. and Petersen, G.M. (2004). Role and limitations of epidemiology in establishing a casual association. Semin. Cancer Biol., 14, 413-426.
113. Goodman G.E., Thornquist, M.D., Balmes, J., Cullen, R.M., Meysken, F.L., Omenn, G. S., Valanis, G.S. and Williams, J.H. (2004). The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6 year follow-up after stopping beta-carotene and retinol supplements. J. Natl. Cancer Instit., 96, 1743-1750.
114. Shuin, T., Nishimura, R., Noda, K., Umeda, M., and Ono, T. (1983) Concentration- dependent differential effect of retinoid acid on intercellular metabolic cooperation. Gann, 74, 100-105.
115. He, K., Nukada, H., Urakami, T. and Murphy, M.P. (2003). Antioxidant and prooxidant properties of pyrroloquinoline quinine (PQQ): Implications for its function in biological systems. Biochem. Pharmocol., 65, 67-74.
116. Henning, H., Wenk, M.L., Dohahoe, R. (1982). Retinoic acid promotion of papilloma formation in mouse skin. Cancer Letters, 16, 1-5.
117. Cohen, G.M., Bracken, W.H., Iyer, R.P., Berry, D.L., Selkirk, J.K., and Slaga, T. J. Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo -p-dioxin on benzo(a) pyrene and 7,12-dimethylbenz (a) anthrcene tumor initiation and its relationship to DNA binding. Cancer Res., 39, 4027-4033.
118. Kushida, M., Sukata, T., Uwagawa, S., Ozaki, K., Kinoshita, A., Wanibusbuchi, H., Morimura, K., Okuno, Y. and Fukushima, S. (2005). Low dose DDT inhibition of hepatocarcinogenesis by diethylnitrosamine in male rats: Possible mechanisms. Toxicol. Appl. Pharmacol., 208, 285-294.
119. Lee, G.H. (2000). Paradoxical effects of Phenobarbital on mouse hepatocarcinogenesis. Toxicol. Pathol., 28, 215-225.
120. Kelloff, G.J., Lippman, S.M., Dannenberg, A.J., Sigman, C.C.H.L., Reid, B.J., Szabo, E., Jordan, V.C., Spitz, M.R., Mills, G.B., Papadimitrakopoulou, V.A., Lotan, R., Aggarwal, B.B., Bresalier, R.S., Banu Arun, J.K., Lu, K.H., Thomas, M.E., Rhodes, H. E., Brewer, M.A., Follen, M., Shin, D.M., Parnes, H.L., Siegfried, J.M., Evans, A.A., Blot, W.J., Chow, W.-H., Blount, P.L., Maley, C.C., Wang, K.K., Lam, S., Lee, J.J., Dubinett, S.M., Engstrom, P.F., Meyskens, Jr. F.L., O'Shaughnessy, J., Hawk, E.T., Levin, B., Nelson, W.G., Hong, W. K. (2006). Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer-A Plan to Move Forward. Clin. Cancer Res., 12, 3661-3697.
121. Upham, B.L., K.-S. Kang, H.-Y Cho, J.E. Trosko (1997). Hydrogen peroxide inhibits gap junction intercellular communication in glutathione sufficient but not glutathione deficient cells. Carcinogenesis., 18, 37-42.
122. Coffey, D.S. (2001). Similarities of prostate and breast cancer: Evolution, diet and estrogens. Urology, 57, 31-38.
123. Grover, P.L. and Martin, F.L. (2002). The initiation of breast and prostate cancer. Carcinogenesis, 23, 1095-1102.
124. Trosko, J.E. (1984). Scientific views of human nature: Implications for the ethics of technological intervention. In D. H. Brock (Ed). The Culture of Biomedicine (Vol. 1., pp. 70-97) Newark: University of Delaware Press.
125. Thompson, D.E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Preston, D.L. (1994). Cancer incidence in atom bomb survivors. Part II: Solid tumors 1958-1987. Radiat. Res., 137, S17-S67.
126. Murrill, W. B., Brown, N., Zhang, J.X., Manzolillo, A., Barnes, S. and Lamartiniere, C.A. (1996). Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis, 17, 1451-1457.
127. Kennedy, A.R. (1998). The Bowman-Birk inhibitor from soy beans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68, 1406s-1412s.
128. Hsieh C.Y. and Chang, C.C. (1999) Stem cell differentiation and reduction as a potential mechanism for chemoprevention of breast cancer. Chinese Pharm. J., 51, 15-30.
129. Ju, Y. H., Allred, C.D., Allred, K.F., Karko, K.L., Doerge, D.R. and Helferich, W.G. (2001). Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic mice. J. Nutr., 131, 2957-2962.
130. Trosko, J.E. (2003) Human stem cells as targets for the aging and diseases of aging processes. Medical Hypo., 60, 439-447.
131. Trosko, J.E. (2007). Aging as the 'System's' Breakdown of Communication between the Quality and Quantity of Stem Cells. In The "Manifesto" For a Long Life. In Press.
132. Ho, S.M., Tang, W.Y., de Frauto, J.B., and Prins, G.S. (2006). Developmental exposures to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase Type 4 Variant 4. Cancer Res., 66, 5624-5632.
133. Dolinoy, D.C., Weidman, J.R., Waterland, R.A. and Jirtle, R. I. (2006). Maternal genistein alters coat color and protects AVY mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect., 114, 567-572.
134. Moghadasian, M.H. and Frohlich, J.J. (1999). Effects of dietary phytoterols on cholesterol metabolism and atherosclerosis: Clinical and experimental evidence. American J. Med., 107, 588-94.
135. De la Puerta, R., Martinez-Dominguez, E., and Riuz-Gutierrez, V. (2000). Effect of minor componbents of virgin olive oil on topical antiinflammatory sassays. Z. Naturforsch. C., 55, 814-819.